Description
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)
CME Available: https://auau.auanet.org/node/39603
Release Date: December, 2023
Expiration Date: December, 2024
LEARNING OBJECTIVES:
At the conclusion of this activity, the learner will be able to:
1. Review recommended criteria for genetic testing of prostate cancer patients, currently available gene panels, and options for testing these men.
2. Explain the importance of testing for germline and somatic mutations and their implications for utilizing PARPi.
3. Describe work flows for genetic testing and utilization of genetic counselors.
4. Describe the genetic counseling process and the importance of pre-test counseling to discuss the benefits, limitations, and potential implications of germline testing for patients and their families.
ACKNOWLEDGEMENT
This educational activity is supported by an independent educational grant from Pfizer, Inc.
Journal Club 101
Guest: Melissa Kaufman, MD, PHD, FACS
Outline:
Segment #1: History of peer review
Segment #2: Models of peer review
Segment #3: General review best practices
Segment #4: General structure for manuscript review
Segment #5: Granular aspects of manuscript review
Published 04/24/24
BPH: Surgical Treatment
Guest: Bilal Chughtai, MD
Outline:
Segment #1: Bladder Health
Segment #2: Diagnostics
Segment #3: Stents
Segment #4: New MISTs
Published 04/17/24